WebMEDFORD, N.Y., March 15, 2024 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious … Web1 day ago · Requests for documents and questions regarding the tender offer may be directed to Alliance Advisors, LLC, the Information Agent for the tender offer, by …
Did you know?
WebMEDFORD, N.Y., April 10, 2024 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the... WebJan 31, 2024 · Pursuant to the Merger Agreement, and upon the terms and subject to the conditions described therein, Merger Sub will commence a tender offer (the “Offer”) to purchase all of the outstanding...
WebBiosynex has extended the tender offer to acquire Chembio Diagnostics ( NASDAQ: CEMI) once again, this time to April 26, from April 12. Biosynex noted that as of April 12, … WebApr 6, 2024 · About CEMI Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that …
WebJan 31, 2024 · CHEMBIO STOCKHOLDERS ARE URGED TO READ THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS), THE SOLICITATION / RECOMMENDATION STATEMENT AND OTHER RELEVANT … WebMar 15, 2024 · MEDFORD, N.Y., March 15, 2024 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the...
WebApr 10, 2024 · Pursuant to the Merger Agreement, the Purchaser commenced a tender offer (the “Offer”) to purchase all of the issued and outstanding shares of the Company’s common stock, par value $0.01 per share (the “Shares”), for a purchase price of $0.45 per share, net to the seller in cash, without interest and subject to any required tax withholding.
WebMar 29, 2024 · Chembio Diagnostics, Inc. (CEMI) is the subject of an extended Offer to Purchase (The “Offer”), as described below: Purchaser:Project Merci Merger Sub, Inc., a … brian starks michiganWebApr 13, 2024 · Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. Chembio Diagnostics board recommends stockholders tender shares Chembio Stockholders Reminded to Tender Shares... courtyard by marriott westminster coloradoWebApr 10, 2024 · MEDFORD, N.Y., April 10, 2024 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA.April 10, 2024. Fellow Chembio Stockholders, As … brian starnes 31 of north carolinaWebApr 13, 2024 · Requests for documents and questions regarding the tender offer may be directed to Alliance Advisors, LLC, the Information Agent for the tender offer, by telephone (toll-free) at 866-620-7692 or by email at [email protected]. About Biosynex courtyard by marriott west orange new jerseyWebMar 15, 2024 · To the extent stockholders want to tender their Shares before the offer closes, they should contact Alliance Advisors at 866-620-7692 or … brian stark and john cochran real estateWebBiosynex has extended the tender offer to acquire Chembio Diagnostics ( NASDAQ: CEMI) once again, this time to April 26, from April 12. Biosynex noted that as of April 12, ~17.74M shares were... courtyard by marriott westwoodWebApr 13, 2024 · Requests for documents and questions regarding the tender offer may be directed to Alliance Advisors, LLC, the Information Agent for the tender offer, by … courtyard by marriott west middleton wi